DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Liesenfeld KH, Lehr T, Dansirikul C , et al.
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.
J Thromb Haemost 2011;
9 (11) 2168-2175
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.